US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Fate Therapeutics

2.33

-0.1100-4.51%

Post-market: 2.330.00000.00%16:10 EDT

Volume:751.11K

Turnover:1.75M

Market Cap:279.60M

PE:-2.21

High:2.45

Open:2.42

Low:2.28

Close:2.44

52wk High:3.23

52wk Low:0.9401

Shares:120.00M

Float Shares:104.94M

Volume Ratio:0.75

T/O Rate:0.72%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0528

EPS(LYR):-1.1500

ROE:-60.75%

ROA:-26.22%

PB:1.82

PE(LYR):-2.03

Loading ...

Overview Company News Filings

Fate Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Fate Therapeutics Q1 operating loss narrows, cash runway extended into 2028

Fate Therapeutics Q1 EPS $(0.26) Beats $(0.28) Estimate, Sales $1.299M Beat $1.139M Estimate

Benzinga Earnings

Fate Therapeutics Q1 FY26 net loss narrows 17.04% to $31.21 million

Fate Therapeutics Q1 Operating Expenses USD 34.299 Million

THOMSON REUTERS

Fate Therapeutics Reports First Quarter 2026 Financial Results and Business Updates

Fate Therapeutics says FT819 achieves low disease activity in SLE without chemotherapy conditioning

Fate Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview

Piper Sandler Remains a Buy on Fate Therapeutics (FATE)

Fate Therapeutics Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of FT819

Fate Therapeutics posts Phase 1 FT819 lupus data showing B-cell remodeling without chemo conditioning

Fate Therapeutics Announces Three Presentations at the 2026 Asgct Annual Meeting Highlighting off-the-Shelf Car T-Cell Therapy Pipeline for Cancer and Autoimmune Diseases

THOMSON REUTERS

Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases

Fate Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Fate Therapeutics price target raised to $7 from $5 at H.C. Wainwright

Fate Therapeutics grants 30,200 RSUs to newly hired employee under inducement plan

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting

Fate Therapeutics announces annual shareholder meeting

Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at the AACR Annual Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/FATE/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FATE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FATE\",,,,,undefined,":{"symbol":"FATE","market":"US","secType":"STK","nameCN":"Fate Therapeutics","latestPrice":2.33,"timestamp":1789070400000,"preClose":2.44,"halted":0,"volume":751110,"hourTrading":{"tag":"盘后","latestPrice":2.33,"preClose":2.33,"latestTime":"16:10 EDT","volume":1157,"amount":2695.779918,"timestamp":1789071008168,"change":0,"changeRate":0,"amplitude":0.012833},"delay":0,"changeRate":-0.04508196721311471,"floatShares":104935918,"shares":120000000,"eps":-1.052849,"marketStatus":"Post-Mkt","change":-0.11,"latestTime":"09-10 18:12:58 EDT","open":2.42,"high":2.45,"low":2.28,"amount":1750663,"amplitude":0.069672,"askPrice":2.6,"askSize":100,"bidPrice":2.33,"bidSize":25,"shortable":3,"etf":0,"ttmEps":-1.052849,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1380600000000,"exchange":"NASDAQ","adjPreClose":2.44,"preHourTrading":{"tag":"盘前","latestPrice":2.43,"preClose":2.44,"latestTime":"08:57 EDT","volume":701,"amount":1698.8618634,"timestamp":1789045021587,"change":-0.01,"changeRate":-0.004098,"amplitude":0.22541},"postHourTrading":{"tag":"盘后","latestPrice":2.33,"preClose":2.33,"latestTime":"16:10 EDT","volume":1157,"amount":2695.779918,"timestamp":1789071008168,"change":0,"changeRate":0,"amplitude":0.012833},"volumeRatio":0.7485,"impliedVol":1.0765,"impliedVolPercentile":0.4661},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FATE\",,,,,undefined,":{"symbol":"FATE","floatShares":104935918,"roa":"-26.22%","roe":"-60.75%","lyrEps":-1.149999,"volumeRatio":0.7485,"shares":120000000,"dividePrice":0,"high":2.45,"amplitude":0.069672,"preClose":2.44,"low":2.28,"week52Low":0.9401,"pbRate":"1.82","psRate":"43.08","week52High":3.23,"institutionHeld":0,"latestPrice":2.33,"committee":-0.6,"eps":-1.052849,"divideRate":0,"volume":751110,"delay":0,"ttmEps":-1.052849,"open":2.42,"prevYearClose":0.9826,"prevWeekClose":2.48,"prevMonthClose":2.39,"prevQuarterClose":2.7,"fiveDayClose":2.45,"twentyDayClose":2.72,"sixtyDayClose":2.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FATE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"FATE","fiscalQuarterEnding":"2026/06","expectedEps":-0.28,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-0.25},{"market":"US","date":"2026-05-13","symbol":"FATE","fiscalQuarterEnding":"2026/03","expectedEps":-0.29,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2026-02-26","symbol":"FATE","fiscalQuarterEnding":"2025/12","expectedEps":-0.27,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":-0.27},{"market":"US","date":"2025-11-13","symbol":"FATE","fiscalQuarterEnding":"2025/09","expectedEps":-0.29,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-0.27},{"market":"US","date":"2025-08-12","symbol":"FATE","fiscalQuarterEnding":"2025/06","expectedEps":-0.35,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FATE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FATE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.25,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":12,"updateTime":1763438400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FATE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FATE","date":"2026-09-09","current":-2.213043,"percent":0.388072,"low":-32.144656,"twenty":-9.282955,"median":-2.056377,"eighty":-0.879401,"high":-0.418369,"avg":-5.476518,"sd":7.510223,"marketCap":299551285},"quantilePoints":[{"date":"2021-09-10","current":-30.721492,"twenty":-27.651256,"median":-15.221651,"eighty":-5.755196,"marketCap":6513478551},{"date":"2021-09-17","current":-32.144656,"twenty":-28.024122,"median":-15.325526,"eighty":-5.861615,"marketCap":6815213565},{"date":"2021-09-24","current":-29.114259,"twenty":-28.520934,"median":-15.428242,"eighty":-5.947899,"marketCap":6172717872},{"date":"2021-10-01","current":-26.712389,"twenty":-28.770745,"median":-15.508466,"eighty":-6.025555,"marketCap":5663480546},{"date":"2021-10-08","current":-24.660698,"twenty":-28.770745,"median":-15.596295,"eighty":-6.049632,"marketCap":5228487166},{"date":"2021-10-15","current":-27.493558,"twenty":-28.770745,"median":-15.645256,"eighty":-6.155927,"marketCap":5829101658},{"date":"2021-10-22","current":-26.487915,"twenty":-28.770745,"median":-15.740705,"eighty":-6.259448,"marketCap":5615888273},{"date":"2021-10-29","current":-24.153387,"twenty":-28.770745,"median":-15.81191,"eighty":-6.361908,"marketCap":5120928628},{"date":"2021-11-05","current":-29.827166,"twenty":-28.923608,"median":-15.934086,"eighty":-6.488617,"marketCap":5865243691},{"date":"2021-11-12","current":-27.122227,"twenty":-29.103484,"median":-15.984397,"eighty":-6.56915,"marketCap":5333341910},{"date":"2021-11-19","current":-27.180503,"twenty":-29.103484,"median":-16.045008,"eighty":-6.623797,"marketCap":5344801194},{"date":"2021-11-26","current":-25.505092,"twenty":-29.103484,"median":-16.092705,"eighty":-6.672691,"marketCap":5015346770},{"date":"2021-12-03","current":-23.310061,"twenty":-29.103484,"median":-16.181629,"eighty":-6.773049,"marketCap":4583713728},{"date":"2021-12-10","current":-23.873388,"twenty":-29.103484,"median":-16.31708,"eighty":-6.885527,"marketCap":4694486809},{"date":"2021-12-17","current":-28.5354,"twenty":-29.103484,"median":-16.404964,"eighty":-7.204242,"marketCap":5611229555},{"date":"2021-12-23","current":-31.245194,"twenty":-29.220654,"median":-16.430369,"eighty":-8.562903,"marketCap":6144086276},{"date":"2021-12-31","current":-28.413993,"twenty":-29.229395,"median":-16.524147,"eighty":-8.877677,"marketCap":5587356046},{"date":"2022-01-07","current":-23.460605,"twenty":-29.260996,"median":-16.542829,"eighty":-9.315158,"marketCap":4613316879},{"date":"2022-01-14","current":-21.017905,"twenty":-29.260996,"median":-16.589142,"eighty":-9.568489,"marketCap":4132981878},{"date":"2022-01-21","current":-18.041016,"twenty":-29.260996,"median":-16.660385,"eighty":-10.010924,"marketCap":3547603437},{"date":"2022-01-28","current":-17.78849,"twenty":-29.260996,"median":-16.780583,"eighty":-10.313437,"marketCap":3497946538},{"date":"2022-02-04","current":-18.895718,"twenty":-29.260996,"median":-16.912923,"eighty":-10.419015,"marketCap":3715672940},{"date":"2022-02-11","current":-18.356673,"twenty":-29.260996,"median":-16.952781,"eighty":-10.529911,"marketCap":3609674560},{"date":"2022-02-18","current":-16.093655,"twenty":-29.260996,"median":-16.996578,"eighty":-10.655948,"marketCap":3164672353},{"date":"2022-02-25","current":-16.962926,"twenty":-29.260996,"median":-16.996578,"eighty":-10.734306,"marketCap":3335606677},{"date":"2022-03-04","current":-14.75839,"twenty":-29.260996,"median":-16.996578,"eighty":-10.825878,"marketCap":3131007191},{"date":"2022-03-11","current":-15.249276,"twenty":-29.260996,"median":-16.996578,"eighty":-10.983123,"marketCap":3235149100},{"date":"2022-03-18","current":-17.158276,"twenty":-29.260996,"median":-17.024176,"eighty":-11.101051,"marketCap":3640145410},{"date":"2022-03-25","current":-17.271907,"twenty":-29.260996,"median":-17.078739,"eighty":-11.454659,"marketCap":3664252334},{"date":"2022-04-01","current":-18.780926,"twenty":-29.260996,"median":-17.143594,"eighty":-11.644942,"marketCap":3984392274},{"date":"2022-04-08","current":-17.262816,"twenty":-29.260996,"median":-17.175687,"eighty":-11.721074,"marketCap":3662323780},{"date":"2022-04-14","current":-17.167366,"twenty":-29.260996,"median":-17.180234,"eighty":-11.77746,"marketCap":3642073964},{"date":"2022-04-22","current":-15.740162,"twenty":-29.260996,"median":-17.180234,"eighty":-11.827773,"marketCap":3339291008},{"date":"2022-04-29","current":-13.002344,"twenty":-29.260996,"median":-17.180234,"eighty":-11.983035,"marketCap":2758460345},{"date":"2022-05-06","current":-10.030241,"twenty":-29.260996,"median":-17.180234,"eighty":-12.029886,"marketCap":2334558693},{"date":"2022-05-13","current":-10.055151,"twenty":-29.260996,"median":-17.180234,"eighty":-12.029886,"marketCap":2340356438},{"date":"2022-05-20","current":-9.590173,"twenty":-29.260996,"median":-17.180234,"eighty":-12.029886,"marketCap":2232131863},{"date":"2022-05-27","current":-9.789449,"twenty":-29.260996,"median":-17.180234,"eighty":-12.029886,"marketCap":2278513824},{"date":"2022-06-03","current":-9.81851,"twenty":-29.260996,"median":-17.180234,"eighty":-12.029886,"marketCap":2285277860},{"date":"2022-06-10","current":-8.2243,"twenty":-29.260996,"median":-17.180234,"eighty":-12.029886,"marketCap":1914222173},{"date":"2022-06-17","current":-8.734945,"twenty":-29.260996,"median":-17.180234,"eighty":-12.029886,"marketCap":2033075948},{"date":"2022-06-24","current":-11.126261,"twenty":-29.264135,"median":-17.183765,"eighty":-12.054049,"marketCap":2589659478},{"date":"2022-07-01","current":-10.437097,"twenty":-29.264135,"median":-17.183765,"eighty":-12.054049,"marketCap":2429255196},{"date":"2022-07-08","current":-12.458921,"twenty":-29.264135,"median":-17.183765,"eighty":-12.132692,"marketCap":2899838840},{"date":"2022-07-15","current":-13.16054,"twenty":-29.264135,"median":-17.183765,"eighty":-12.203857,"marketCap":3063141994},{"date":"2022-07-22","current":-12.886535,"twenty":-29.264135,"median":-17.183765,"eighty":-12.243686,"marketCap":2999366798},{"date":"2022-07-29","current":-12.674804,"twenty":-29.264135,"median":-17.183765,"eighty":-12.362063,"marketCap":2950085965},{"date":"2022-08-05","current":-12.776678,"twenty":-29.264135,"median":-17.183765,"eighty":-12.418475,"marketCap":3241749825},{"date":"2022-08-12","current":-12.9296,"twenty":-29.264135,"median":-17.183765,"eighty":-12.45304,"marketCap":3280549943},{"date":"2022-08-19","current":-11.098353,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":2815918534},{"date":"2022-08-26","current":-10.524894,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":2670418093},{"date":"2022-09-02","current":-10.215225,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":2591847855},{"date":"2022-09-09","current":-10.742808,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":2725708261},{"date":"2022-09-16","current":-9.557659,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":2425007350},{"date":"2022-09-23","current":-8.39927,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":2131096459},{"date":"2022-09-30","current":-8.567485,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":2173776588},{"date":"2022-10-07","current":-8.208117,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":2082596312},{"date":"2022-10-14","current":-7.783757,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":1974925985},{"date":"2022-10-21","current":-7.374689,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":1871135671},{"date":"2022-10-28","current":-8.334278,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":2114606409},{"date":"2022-11-04","current":-6.557821,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":1927861589},{"date":"2022-11-11","current":-7.589091,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":2231033371},{"date":"2022-11-18","current":-6.567737,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":1930776702},{"date":"2022-11-25","current":-6.554515,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":1926889884},{"date":"2022-12-02","current":-6.911494,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":2031833963},{"date":"2022-12-09","current":-6.247118,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":1836521372},{"date":"2022-12-16","current":-4.323402,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":1270989394},{"date":"2022-12-23","current":-3.639194,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":1069846577},{"date":"2022-12-30","current":-3.335101,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":980449769},{"date":"2023-01-06","current":-1.40147,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":412002678},{"date":"2023-01-13","current":-1.784891,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":524720392},{"date":"2023-01-20","current":-1.808028,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":531522323},{"date":"2023-01-27","current":-1.956769,"twenty":-29.264135,"median":-17.183765,"eighty":-12.471418,"marketCap":575249022},{"date":"2023-02-03","current":-2.270778,"twenty":-29.264135,"median":-17.183765,"eighty":-12.452981,"marketCap":667560943},{"date":"2023-02-10","current":-2.05593,"twenty":-29.264135,"median":-17.183765,"eighty":-12.452981,"marketCap":604400155},{"date":"2023-02-17","current":-2.165006,"twenty":-29.264135,"median":-17.183765,"eighty":-12.452981,"marketCap":636466401},{"date":"2023-02-24","current":-1.9138,"twenty":-29.264135,"median":-17.183765,"eighty":-12.418475,"marketCap":562616864},{"date":"2023-03-03","current":-2.128946,"twenty":-29.264135,"median":-17.176703,"eighty":-12.363624,"marketCap":599768738},{"date":"2023-03-10","current":-1.700369,"twenty":-29.264135,"median":-17.176703,"eighty":-12.267829,"marketCap":479029696},{"date":"2023-03-17","current":-1.930337,"twenty":-29.264135,"median":-17.176703,"eighty":-12.199055,"marketCap":543816499},{"date":"2023-03-24","current":-1.878072,"twenty":-29.264135,"median":-17.176703,"eighty":-12.054049,"marketCap":529092225},{"date":"2023-03-31","current":-1.986087,"twenty":-29.260996,"median":-17.175687,"eighty":-11.983035,"marketCap":559522391},{"date":"2023-04-06","current":-1.9164,"twenty":-29.260996,"median":-17.175687,"eighty":-11.960825,"marketCap":539890026},{"date":"2023-04-14","current":-2.160305,"twenty":-29.264135,"median":-17.176703,"eighty":-11.866074,"marketCap":608603302},{"date":"2023-04-21","current":-2.090618,"twenty":-29.267274,"median":-17.180234,"eighty":-11.792439,"marketCap":588970938},{"date":"2023-04-28","current":-2.035862,"twenty":-29.267274,"median":-17.180234,"eighty":-11.732971,"marketCap":573544945},{"date":"2023-05-05","current":-2.584083,"twenty":-29.273552,"median":-17.184286,"eighty":-11.580059,"marketCap":607032093},{"date":"2023-05-12","current":-2.202962,"twenty":-29.273552,"median":-17.184286,"eighty":-11.458423,"marketCap":517502238},{"date":"2023-05-19","current":-2.048001,"twenty":-29.273552,"median":-17.184286,"eighty":-11.288173,"marketCap":481099989},{"date":"2023-05-26","current":-2.110823,"twenty":-29.273552,"median":-17.184286,"eighty":-11.10204,"marketCap":495857658},{"date":"2023-06-02","current":-2.123387,"twenty":-29.273552,"median":-17.184286,"eighty":-11.00819,"marketCap":498809191},{"date":"2023-06-09","current":-2.219715,"twenty":-29.281381,"median":-17.184806,"eighty":-10.903687,"marketCap":521437616},{"date":"2023-06-16","current":-2.43331,"twenty":-29.281381,"median":-17.184806,"eighty":-10.745141,"marketCap":571613689},{"date":"2023-06-23","current":-2.202962,"twenty":-29.29704,"median":-17.187699,"eighty":-10.646331,"marketCap":517502238},{"date":"2023-06-30","current":-2.001931,"twenty":-29.304869,"median":-17.188039,"eighty":-10.54093,"marketCap":470277699},{"date":"2023-07-07","current":-1.955862,"twenty":-29.304869,"median":-17.188039,"eighty":-10.434734,"marketCap":459455409},{"date":"2023-07-14","current":-2.060565,"twenty":-29.304869,"median":-17.188039,"eighty":-10.347241,"marketCap":484051523},{"date":"2023-07-21","current":-1.863723,"twenty":-29.304869,"median":-17.188039,"eighty":-10.277676,"marketCap":437810829},{"date":"2023-07-28","current":-1.717138,"twenty":-29.304869,"median":-17.188039,"eighty":-10.096492,"marketCap":403376269},{"date":"2023-08-04","current":-1.545424,"twenty":-29.304869,"median":-17.188039,"eighty":-10.035223,"marketCap":363038642},{"date":"2023-08-11","current":-1.518768,"twenty":-29.304869,"median":-17.188039,"eighty":-9.874485,"marketCap":321313528},{"date":"2023-08-18","current":-1.295145,"twenty":-29.304869,"median":-17.188039,"eighty":-9.784465,"marketCap":274003560},{"date":"2023-08-25","current":-1.192652,"twenty":-29.304869,"median":-17.188039,"eighty":-9.606608,"marketCap":252319825},{"date":"2023-09-01","current":-1.169358,"twenty":-29.304869,"median":-17.188039,"eighty":-9.385084,"marketCap":247391704},{"date":"2023-09-08","current":-1.150723,"twenty":-29.304869,"median":-17.188039,"eighty":-9.272504,"marketCap":243449207},{"date":"2023-09-15","current":-1.099476,"twenty":-29.304869,"median":-17.188039,"eighty":-9.064582,"marketCap":232607339},{"date":"2023-09-22","current":-1.020276,"twenty":-29.304869,"median":-17.188039,"eighty":-8.882339,"marketCap":215851726},{"date":"2023-09-29","current":-1.015618,"twenty":-29.304869,"median":-17.175687,"eighty":-8.605715,"marketCap":214866101},{"date":"2023-10-06","current":-0.819948,"twenty":-29.304869,"median":-17.151975,"eighty":-8.340395,"marketCap":173469880},{"date":"2023-10-13","current":-0.815289,"twenty":-29.304869,"median":-17.151975,"eighty":-8.163769,"marketCap":172484256},{"date":"2023-10-20","current":-0.955053,"twenty":-29.304869,"median":-17.151975,"eighty":-8.038727,"marketCap":202052985},{"date":"2023-10-27","current":-0.815289,"twenty":-29.335487,"median":-17.158276,"eighty":-8.000143,"marketCap":172484256},{"date":"2023-11-03","current":-1.029594,"twenty":-29.335487,"median":-17.158276,"eighty":-7.705215,"marketCap":217822974},{"date":"2023-11-10","current":-1.212816,"twenty":-29.335487,"median":-17.158276,"eighty":-7.378792,"marketCap":210022187},{"date":"2023-11-17","current":-1.355166,"twenty":-29.335487,"median":-17.158276,"eighty":-7.110178,"marketCap":234672679},{"date":"2023-11-24","current":-1.343778,"twenty":-29.335487,"median":-17.158276,"eighty":-6.784568,"marketCap":232700639},{"date":"2023-12-01","current":-1.417799,"twenty":-29.335487,"median":-17.158276,"eighty":-6.557821,"marketCap":245518895},{"date":"2023-12-08","current":-1.338084,"twenty":-29.324093,"median":-17.143594,"eighty":-6.489731,"marketCap":231714620},{"date":"2023-12-15","current":-1.696804,"twenty":-29.324093,"median":-17.135846,"eighty":-6.325124,"marketCap":293833858},{"date":"2023-12-22","current":-1.907481,"twenty":-29.324093,"median":-17.135846,"eighty":-5.399625,"marketCap":330316586},{"date":"2023-12-29","current":-2.243425,"twenty":-29.335487,"median":-17.138955,"eighty":-4.547505,"marketCap":388491746},{"date":"2024-01-05","current":-2.186486,"twenty":-29.346882,"median":-17.139525,"eighty":-4.099299,"marketCap":378631549},{"date":"2024-01-12","current":-2.533818,"twenty":-29.346882,"median":-17.078739,"eighty":-3.477232,"marketCap":438778748},{"date":"2024-01-19","current":-2.46549,"twenty":-29.358276,"median":-17.078739,"eighty":-3.268333,"marketCap":426946512},{"date":"2024-01-26","current":-2.596452,"twenty":-29.346882,"median":-17.078739,"eighty":-2.59873,"marketCap":449624964},{"date":"2024-02-02","current":-3.849126,"twenty":-29.346882,"median":-17.078739,"eighty":-2.596452,"marketCap":666549290},{"date":"2024-02-09","current":-3.479018,"twenty":-29.346882,"median":-17.078739,"eighty":-2.596452,"marketCap":602458012},{"date":"2024-02-16","current":-4.031333,"twenty":-29.346882,"median":-17.078739,"eighty":-2.596452,"marketCap":698101919},{"date":"2024-02-23","current":-3.917454,"twenty":-29.346882,"median":-17.078739,"eighty":-2.596452,"marketCap":678381526},{"date":"2024-03-01","current":-4.372104,"twenty":-29.335487,"median":-17.078739,"eighty":-2.596452,"marketCap":703593931},{"date":"2024-03-08","current":-5.149093,"twenty":-29.335487,"median":-17.078739,"eighty":-2.596452,"marketCap":828633191},{"date":"2024-03-15","current":-4.458436,"twenty":-29.335487,"median":-17.041439,"eighty":-2.596452,"marketCap":717487182},{"date":"2024-03-22","current":-5.253327,"twenty":-29.335487,"median":-16.914037,"eighty":-2.596452,"marketCap":845407407},{"date":"2024-03-28","current":-5.189693,"twenty":-29.335487,"median":-16.914037,"eighty":-2.596452,"marketCap":835166941},{"date":"2024-04-05","current":-4.928087,"twenty":-29.346882,"median":-16.792385,"eighty":-2.596452,"marketCap":793067245},{"date":"2024-04-12","current":-4.206904,"twenty":-29.346882,"median":-16.683823,"eighty":-2.596452,"marketCap":677008623},{"date":"2024-04-19","current":-3.564552,"twenty":-29.346882,"median":-16.683823,"eighty":-2.596452,"marketCap":573636208},{"date":"2024-04-26","current":-2.737067,"twenty":-29.335487,"median":-16.646001,"eighty":-2.596452,"marketCap":440470659},{"date":"2024-05-03","current":-2.899735,"twenty":-29.335487,"median":-16.635574,"eighty":-2.596452,"marketCap":466648502},{"date":"2024-05-10","current":-2.335924,"twenty":-29.335487,"median":-16.577142,"eighty":-2.594174,"marketCap":443944679},{"date":"2024-05-17","current":-2.479673,"twenty":-29.335487,"median":-16.543987,"eighty":-2.537269,"marketCap":471264351},{"date":"2024-05-24","current":-2.054415,"twenty":-29.335487,"median":-16.422376,"eighty":-2.483267,"marketCap":390443653},{"date":"2024-05-31","current":-2.066394,"twenty":-29.335487,"median":-16.301752,"eighty":-2.439566,"marketCap":392720293},{"date":"2024-06-07","current":-2.276028,"twenty":-29.335487,"median":-16.181629,"eighty":-2.336559,"marketCap":432561482},{"date":"2024-06-14","current":-2.25207,"twenty":-29.346882,"median":-16.160372,"eighty":-2.311899,"marketCap":428008203},{"date":"2024-06-21","current":-2.150248,"twenty":-29.358276,"median":-16.09469,"eighty":-2.27733,"marketCap":408656768},{"date":"2024-06-28","current":-1.955588,"twenty":-29.430291,"median":-16.06224,"eighty":-2.26878,"marketCap":371661378},{"date":"2024-07-05","current":-1.892697,"twenty":-29.430291,"median":-15.913492,"eighty":-2.257858,"marketCap":359709022},{"date":"2024-07-12","current":-2.036447,"twenty":-29.430291,"median":-15.701967,"eighty":-2.241145,"marketCap":387028694},{"date":"2024-07-15","current":-2.162227,"twenty":-29.430291,"median":-15.695149,"eighty":-2.237221,"marketCap":410933408},{"date":"2024-08-02","current":-2.9229,"twenty":-29.632915,"median":-15.457484,"eighty":-2.232279,"marketCap":555500008},{"date":"2024-08-09","current":-2.168217,"twenty":-29.632915,"median":-15.124062,"eighty":-2.219715,"marketCap":412071727},{"date":"2024-08-16","current":-2.196901,"twenty":-29.632915,"median":-15.003689,"eighty":-2.204154,"marketCap":386046026},{"date":"2024-08-23","current":-2.443161,"twenty":-29.632915,"median":-14.848923,"eighty":-2.203381,"marketCap":429319622},{"date":"2024-08-30","current":-2.294109,"twenty":-29.632915,"median":-14.768769,"eighty":-2.203381,"marketCap":403127709},{"date":"2024-09-06","current":-2.300589,"twenty":-29.632915,"median":-14.75839,"eighty":-2.203381,"marketCap":404266488},{"date":"2024-09-13","current":-2.42372,"twenty":-29.632915,"median":-14.544828,"eighty":-2.202962,"marketCap":425903286},{"date":"2024-09-20","current":-2.592214,"twenty":-29.632915,"median":-14.418351,"eighty":-2.202962,"marketCap":455511536},{"date":"2024-09-27","current":-2.268187,"twenty":-29.632915,"median":-14.282146,"eighty":-2.202962,"marketCap":398572594},{"date":"2024-10-04","current":-2.021927,"twenty":-29.632915,"median":-14.136211,"eighty":-2.198164,"marketCap":355298998},{"date":"2024-10-11","current":-1.905277,"twenty":-29.632915,"median":-13.841401,"eighty":-2.186486,"marketCap":334800978},{"date":"2024-10-18","current":-2.086732,"twenty":-29.632915,"median":-13.749896,"eighty":-2.165006,"marketCap":366686786},{"date":"2024-10-25","current":-1.82103,"twenty":-29.632915,"median":-13.485723,"eighty":-2.160305,"marketCap":319996854},{"date":"2024-10-31","current":-1.613653,"twenty":-29.632915,"median":-13.300956,"eighty":-2.138269,"marketCap":283555931},{"date":"2024-11-08","current":-1.652536,"twenty":-29.63816,"median":-13.092081,"eighty":-2.121977,"marketCap":290388604},{"date":"2024-11-15","current":-1.329175,"twenty":-29.63816,"median":-13.092081,"eighty":-2.115835,"marketCap":236900212},{"date":"2024-11-22","current":-1.322785,"twenty":-29.63816,"median":-13.092081,"eighty":-2.107984,"marketCap":235761269},{"date":"2024-11-29","current":-2.025714,"twenty":-29.63816,"median":-13.015017,"eighty":-2.100513,"marketCap":361045035},{"date":"2024-12-06","current":-1.520883,"twenty":-29.63816,"median":-12.996334,"eighty":-2.090291,"marketCap":271068512},{"date":"2024-12-13","current":-1.230126,"twenty":-29.63816,"median":-12.808773,"eighty":-2.085691,"marketCap":219246591},{"date":"2024-12-20","current":-1.060784,"twenty":-29.63816,"median":-12.695562,"eighty":-2.075643,"marketCap":189064592},{"date":"2024-12-27","current":-1.035223,"twenty":-29.63816,"median":-12.512887,"eighty":-2.063113,"marketCap":184508819},{"date":"2025-01-03","current":-1.143857,"twenty":-29.63816,"median":-12.419221,"eighty":-2.054415,"marketCap":203870856},{"date":"2025-01-10","current":-1.067174,"twenty":-29.643406,"median":-11.836183,"eighty":-2.045775,"marketCap":190203536},{"date":"2025-01-17","current":-0.798783,"twenty":-29.643406,"median":-11.408021,"eighty":-2.036213,"marketCap":142367916},{"date":"2025-01-24","current":-0.856296,"twenty":-29.643406,"median":-11.098353,"eighty":-2.029248,"marketCap":152618406},{"date":"2025-01-31","current":-0.875466,"twenty":-29.643406,"median":-10.632222,"eighty":-2.02342,"marketCap":156035236},{"date":"2025-02-07","current":-0.894637,"twenty":-29.643406,"median":-10.33374,"eighty":-2.016026,"marketCap":159452066},{"date":"2025-02-14","current":-0.811564,"twenty":-29.643406,"median":-10.215225,"eighty":-1.993963,"marketCap":144645802},{"date":"2025-02-21","current":-0.987296,"twenty":-29.643406,"median":-10.030241,"eighty":-1.986087,"marketCap":175966744},{"date":"2025-02-28","current":-0.696539,"twenty":-29.643406,"median":-9.851723,"eighty":-1.976563,"marketCap":124144822},{"date":"2025-03-07","current":-0.639858,"twenty":-29.648651,"median":-9.723024,"eighty":-1.960368,"marketCap":119181322},{"date":"2025-03-14","current":-0.580487,"twenty":-29.648651,"median":-9.573916,"eighty":-1.953447,"marketCap":108122670},{"date":"2025-03-21","current":-0.576303,"twenty":-29.648651,"median":-9.305789,"eighty":-1.9387,"marketCap":107343407},{"date":"2025-03-28","current":-0.542403,"twenty":-29.648651,"median":-9.121929,"eighty":-1.928247,"marketCap":101029089},{"date":"2025-04-04","current":-0.418369,"twenty":-29.648651,"median":-8.989933,"eighty":-1.91484,"marketCap":77926249},{"date":"2025-04-11","current":-0.57538,"twenty":-29.643406,"median":-8.776461,"eighty":-1.906599,"marketCap":107171511},{"date":"2025-04-17","current":-0.646011,"twenty":-29.643406,"median":-8.567485,"eighty":-1.892697,"marketCap":120327296},{"date":"2025-04-25","current":-0.830633,"twenty":-29.648651,"median":-8.248704,"eighty":-1.882253,"marketCap":154715278},{"date":"2025-05-02","current":-0.762951,"twenty":-29.648651,"median":-8.104895,"eighty":-1.868739,"marketCap":142108848},{"date":"2025-05-09","current":-0.633742,"twenty":-29.648651,"median":-8.013141,"eighty":-1.861437,"marketCap":118042027},{"date":"2025-05-16","current":-0.65829,"twenty":-29.648651,"median":-7.759085,"eighty":-1.821547,"marketCap":115779352},{"date":"2025-05-23","current":-0.782126,"twenty":-29.648651,"median":-7.448835,"eighty":-1.79892,"marketCap":137559626},{"date":"2025-05-30","current":-0.860339,"twenty":-29.648651,"median":-7.301888,"eighty":-1.790186,"marketCap":151315589},{"date":"2025-06-06","current":-0.873375,"twenty":-29.648651,"median":-6.847039,"eighty":-1.762906,"marketCap":153608249},{"date":"2025-06-13","current":-0.912481,"twenty":-29.648651,"median":-6.562779,"eighty":-1.737331,"marketCap":160486230},{"date":"2025-06-20","current":-0.788644,"twenty":-29.653897,"median":-6.495019,"eighty":-1.717179,"marketCap":138705956},{"date":"2025-06-27","current":-0.716949,"twenty":-29.653897,"median":-6.36611,"eighty":-1.683196,"marketCap":126096324},{"date":"2025-07-03","current":-0.729985,"twenty":-29.653897,"median":-6.247118,"eighty":-1.646151,"marketCap":128388984},{"date":"2025-07-11","current":-0.756056,"twenty":-29.653897,"median":-5.253327,"eighty":-1.574747,"marketCap":132974305},{"date":"2025-07-18","current":-0.749538,"twenty":-29.653897,"median":-5.007261,"eighty":-1.529873,"marketCap":131827975},{"date":"2025-07-25","current":-0.814715,"twenty":-29.653897,"median":-4.920929,"eighty":-1.495237,"marketCap":143291277},{"date":"2025-08-01","current":-0.716949,"twenty":-29.653897,"median":-4.80789,"eighty":-1.451868,"marketCap":126096324},{"date":"2025-08-08","current":-0.638802,"twenty":-29.653897,"median":-4.711266,"eighty":-1.417967,"marketCap":112351824},{"date":"2025-08-15","current":-0.719457,"twenty":-29.653897,"median":-4.458436,"eighty":-1.393467,"marketCap":123402775},{"date":"2025-08-22","current":-0.746353,"twenty":-29.653897,"median":-4.341271,"eighty":-1.366554,"marketCap":128015963},{"date":"2025-08-29","current":-0.726181,"twenty":-29.653897,"median":-4.214325,"eighty":-1.343778,"marketCap":124556072},{"date":"2025-09-05","current":-0.654168,"twenty":-29.659142,"median":-4.040195,"eighty":-1.322785,"marketCap":112204262},{"date":"2025-09-12","current":-0.685838,"twenty":-29.653897,"median":-3.917454,"eighty":-1.298226,"marketCap":117636290},{"date":"2025-09-19","current":-0.67239,"twenty":-29.653897,"median":-3.80389,"eighty":-1.275971,"marketCap":115329697},{"date":"2025-09-26","current":-0.652756,"twenty":-29.653897,"median":-3.639194,"eighty":-1.243899,"marketCap":111962069},{"date":"2025-10-03","current":-0.813592,"twenty":-29.479516,"median":-3.564552,"eighty":-1.215305,"marketCap":139548933},{"date":"2025-10-10","current":-1.082548,"twenty":-29.194086,"median":-3.37146,"eighty":-1.188925,"marketCap":185680812},{"date":"2025-10-17","current":-1.035481,"twenty":-28.952941,"median":-3.259078,"eighty":-1.169358,"marketCap":177607733},{"date":"2025-10-24","current":-1.022033,"twenty":-28.299428,"median":-3.041185,"eighty":-1.138168,"marketCap":175301139},{"date":"2025-10-31","current":-0.867383,"twenty":-27.440798,"median":-2.871445,"eighty":-1.110246,"marketCap":148775309},{"date":"2025-11-07","current":-0.699286,"twenty":-27.157193,"median":-2.744139,"eighty":-1.089314,"marketCap":119942884},{"date":"2025-11-14","current":-0.667343,"twenty":-26.927336,"median":-2.616834,"eighty":-1.068452,"marketCap":114464076},{"date":"2025-11-21","current":-0.738992,"twenty":-26.708238,"median":-2.592214,"eighty":-1.049462,"marketCap":115352289},{"date":"2025-11-28","current":-0.842451,"twenty":-26.543219,"median":-2.57937,"eighty":-1.035481,"marketCap":131501609},{"date":"2025-12-05","current":-0.812892,"twenty":-26.107179,"median":-2.533889,"eighty":-1.028772,"marketCap":126887517},{"date":"2025-12-12","current":-0.820282,"twenty":-25.83262,"median":-2.514447,"eighty":-1.01655,"marketCap":128041040},{"date":"2025-12-19","current":-0.775942,"twenty":-25.454477,"median":-2.488525,"eighty":-1.001861,"marketCap":121119903},{"date":"2025-12-26","current":-0.746382,"twenty":-25.310403,"median":-2.46549,"eighty":-0.98737,"marketCap":116505811},{"date":"2026-01-02","current":-0.726134,"twenty":-25.120251,"median":-2.43331,"eighty":-0.970766,"marketCap":113345159},{"date":"2026-01-09","current":-0.783332,"twenty":-24.118755,"median":-2.378356,"eighty":-0.93735,"marketCap":122273426},{"date":"2026-01-16","current":-0.775942,"twenty":-23.430496,"median":-2.336983,"eighty":-0.926765,"marketCap":121119903},{"date":"2026-01-23","current":-0.923741,"twenty":-21.705552,"median":-2.324418,"eighty":-0.90748,"marketCap":144190361},{"date":"2026-01-30","current":-0.879401,"twenty":-19.854345,"median":-2.296195,"eighty":-0.902286,"marketCap":137269223},{"date":"2026-02-06","current":-0.775942,"twenty":-19.222059,"median":-2.276028,"eighty":-0.894243,"marketCap":121119903},{"date":"2026-02-13","current":-0.886791,"twenty":-19.029328,"median":-2.268187,"eighty":-0.879401,"marketCap":138422746},{"date":"2026-02-20","current":-1.034589,"twenty":-18.511649,"median":-2.25806,"eighty":-0.879401,"marketCap":161493204},{"date":"2026-02-27","current":-1.320101,"twenty":-18.197318,"median":-2.243425,"eighty":-0.879401,"marketCap":179949570},{"date":"2026-03-06","current":-1.177006,"twenty":-17.690079,"median":-2.235784,"eighty":-0.879401,"marketCap":160443573},{"date":"2026-03-13","current":-0.997896,"twenty":-17.354948,"median":-2.216133,"eighty":-0.879401,"marketCap":136028247},{"date":"2026-03-20","current":-0.921135,"twenty":-17.165548,"median":-2.203381,"eighty":-0.879401,"marketCap":125564535},{"date":"2026-03-27","current":-1.049071,"twenty":-16.774658,"median":-2.196901,"eighty":-0.879401,"marketCap":143004054},{"date":"2026-04-02","current":-1.0576,"twenty":-16.389833,"median":-2.186486,"eighty":-0.879401,"marketCap":144166689},{"date":"2026-04-10","current":-1.083187,"twenty":-16.120144,"median":-2.165006,"eighty":-0.879401,"marketCap":147654592},{"date":"2026-04-17","current":-1.168477,"twenty":-15.73289,"median":-2.160305,"eighty":-0.879401,"marketCap":159280938},{"date":"2026-04-24","current":-1.125832,"twenty":-15.415842,"median":-2.135258,"eighty":-0.879401,"marketCap":153467765},{"date":"2026-05-01","current":-1.066129,"twenty":-14.708566,"median":-2.121977,"eighty":-0.879401,"marketCap":145329323},{"date":"2026-05-08","current":-2.072879,"twenty":-13.830314,"median":-2.115011,"eighty":-0.879401,"marketCap":282564513},{"date":"2026-05-15","current":-1.704777,"twenty":-13.491278,"median":-2.106635,"eighty":-0.879401,"marketCap":221462453},{"date":"2026-05-22","current":-1.884227,"twenty":-13.075716,"median":-2.095594,"eighty":-0.879401,"marketCap":244774290},{"date":"2026-05-29","current":-2.35977,"twenty":-12.9296,"median":-2.091915,"eighty":-0.879401,"marketCap":306550659},{"date":"2026-06-05","current":-1.982925,"twenty":-12.757835,"median":-2.088983,"eighty":-0.879401,"marketCap":257595801},{"date":"2026-06-12","current":-1.767584,"twenty":-12.573291,"median":-2.085678,"eighty":-0.879401,"marketCap":229621596},{"date":"2026-06-18","current":-1.758612,"twenty":-12.468885,"median":-2.077318,"eighty":-0.879401,"marketCap":228456004},{"date":"2026-06-26","current":-1.677859,"twenty":-11.886002,"median":-2.062158,"eighty":-0.879401,"marketCap":217965677},{"date":"2026-07-02","current":-2.709698,"twenty":-11.580059,"median":-2.058471,"eighty":-0.879401,"marketCap":352008741},{"date":"2026-07-10","current":-2.790451,"twenty":-11.126261,"median":-2.058471,"eighty":-0.879401,"marketCap":362499068},{"date":"2026-07-17","current":-2.449495,"twenty":-10.742808,"median":-2.058471,"eighty":-0.879401,"marketCap":318206577},{"date":"2026-07-24","current":-2.261073,"twenty":-10.341387,"median":-2.058471,"eighty":-0.879401,"marketCap":293729148},{"date":"2026-07-31","current":-2.2521,"twenty":-10.277676,"median":-2.056377,"eighty":-0.879401,"marketCap":292563556},{"date":"2026-08-07","current":-2.234155,"twenty":-10.035223,"median":-2.056377,"eighty":-0.879401,"marketCap":290232373},{"date":"2026-08-14","current":-2.331258,"twenty":-9.853384,"median":-2.056377,"eighty":-0.879401,"marketCap":293729148},{"date":"2026-08-21","current":-2.329917,"twenty":-9.75499,"median":-2.056377,"eighty":-0.879401,"marketCap":293560259},{"date":"2026-08-28","current":-2.415506,"twenty":-9.590173,"median":-2.056377,"eighty":-0.879401,"marketCap":304344105},{"date":"2026-09-04","current":-2.301388,"twenty":-9.326131,"median":-2.056377,"eighty":-0.879401,"marketCap":289965643},{"date":"2026-09-09","current":-2.377467,"twenty":-9.282955,"median":-2.056377,"eighty":-0.879401,"marketCap":299551285}],"updateTime":1789078371074},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FATE\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635078742","title":"Fate Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635078742","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635078742?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:03","pubTimestamp":1778677436,"startTime":"0","endTime":"0","summary":"Fate Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryFate Therapeutics Inc FATE.OQ reported a quarterly adjusted loss of 26 cents per share for the quarter ended Marc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nL8N41Q1Q3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FATE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635782213","title":"Fate Therapeutics Q1 operating loss narrows, cash runway extended into 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2635782213","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635782213?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:40","pubTimestamp":1778676014,"startTime":"0","endTime":"0","summary":"Fate Therapeutics Q1 operating loss narrows, cash runway extended into 2028OverviewBiopharmaceutical firm's Q1 collaboration revenue declined yr/yrQ1 operating expenses fell 20% from prior year, exten","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nL1N41Q0LR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FATE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635782600","title":"Fate Therapeutics Q1 EPS $(0.26) Beats $(0.28) Estimate, Sales $1.299M Beat $1.139M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635782600","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635782600?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:33","pubTimestamp":1778675584,"startTime":"0","endTime":"0","summary":"Fate Therapeutics (NASDAQ:FATE) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.28) by 7.14 percent. This is a 18.75 percent increase over losses of $(0.32) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52520159/fate-therapeutics-q1-eps-0-26-beats-0-28-estimate-sales-1-299m-beat-1-139m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FATE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635782627","title":"Fate Therapeutics Q1 FY26 net loss narrows 17.04% to $31.21 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635782627","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635782627?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:32","pubTimestamp":1778675533,"startTime":"0","endTime":"0","summary":"Fate Therapeutics posted a first-quarter net loss of USD 31.21 million, narrowing from USD 37.62 million a year earlier, while operating loss improved to USD 33 million from USD 41.28 million.Revenue slipped to USD 1.3 million from USD 1.63 million, while total operating expenses fell 20% year over year to USD 34.3 million.Cash, cash equivalents, and investments totaled USD 174.8 million at March 31, supporting an operating runway into 2028.RECLAIM-LN, a Phase 2 potentially registrational trial of FT819 in lupus nephritis, remained on track to start patient dosing in second-half 2026, targeting about 53 patients and using a single 900 million-cell dose following bendamustine conditioning.FT819 was selected for FDA CDRP participation to increase CMC-focused interactions, while FT839 IND filing and Phase 1 enrollment are planned for second-half 2026 and FT836 Phase 1 study had treated nine patients as of April 20 with updated data expected at ASCO in June.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL8Ds2wD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4588","LU2095319765.USD","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","FATE","SG9999014021.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BGHQF748.EUR","SG9999014005.SGD","NDAQ","LU0314104364.USD","SG9999014039.USD","IE00BN0W2V16.EUR","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635782592","title":"Fate Therapeutics Q1 Operating Expenses USD 34.299 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635782592","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635782592?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:30","pubTimestamp":1778675401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nPLXADB87B:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FATE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635782088","title":"Fate Therapeutics Reports First Quarter 2026 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2635782088","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635782088?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:30","pubTimestamp":1778675400,"startTime":"0","endTime":"0","summary":"RECLAIM – LN, a Phase 2 potentially registrational clinical trial of FT819 in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE) with lupus nephritis, on schedule to initia","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3293996/24675/en/Fate-Therapeutics-Reports-First-Quarter-2026-Financial-Results-and-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014567.USD","LU0949170772.SGD","LU0096364046.USD","LU2506951875.HKD","BK4504","LU2133065610.SGD","CMC","RA","BK4559","IIM","LU1894683348.USD","LU0545039389.USD","IE00BVYPNW00.USD","SG9999014559.SGD","SITC","IE00B3PB1722.GBP","BK4080","LU1894683264.USD","LU1920063259.USD","IE00BBT3K403.USD","LU2237443622.USD","LU0170899867.USD","LU1732799900.SGD","LU2746668974.SGD","BK4581","SG9999011175.SGD","LU2125154935.USD","LU2347655156.SGD","SLE","LU1670711123.USD","IE00BLSP4239.USD","LU0971096721.USD","LU0289960550.SGD","CAR","FATE","LU1920062954.HKD","BK4533","KO","LU1221951046.USD","LU2237443465.HKD","LU1868837136.USD","LU2125154778.USD","BK4139","LU1868836591.USD","LU0912757837.SGD","LU0098860793.USD","LU0795875086.SGD","LU0882574139.USD","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634890532","title":"Fate Therapeutics says FT819 achieves low disease activity in SLE without chemotherapy conditioning","url":"https://stock-news.laohu8.com/highlight/detail?id=2634890532","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634890532?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:32","pubTimestamp":1778502750,"startTime":"0","endTime":"0","summary":"Fate Therapeutics presented new Phase 1 data at 2026 ASGCT showing its off-the-shelf CD19 CAR T-cell therapy FT819 produced clinical improvement in active systemic lupus erythematosus without conditioning chemotherapy.Responses were achieved with a single dose given alongside background therapy, supported by evidence of sustained B-cell depletion and reshaping consistent with disease control.Higher-dose dosing has started, setting up a near-term read on whether efficacy and durability extend with greater cell exposure while maintaining the safety profile seen to date.Additional ASGCT presentations will outline preclinical programs FT839 in autoimmune disease and FT836 in cancer, positioning both for broader use without conditioning chemotherapy and for combination strategies with standard-of-care agents.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL8KWZrL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","SG9999014039.USD","LU2210150020.SGD","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014013.SGD","BK4139","LU0314104364.USD","IE00B3QW5Z07.USD","BK4585","BK4588","FATE","LU2095319765.USD","SG9999014021.USD","SG9999014005.SGD","IE00BN0W2W23.USD","BK4112","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","NDAQ","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633804455","title":"Fate Therapeutics Inc  expected to post a loss of 28 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633804455","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633804455?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:54","pubTimestamp":1778241246,"startTime":"0","endTime":"0","summary":"Fate Therapeutics Inc  expected to post a loss of28cents a share - Earnings Preview Fate Therapeutics Inc FATE.OQ FATE.O is expected to  show a fall in quarterly revenue when it reports  results on Ma","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L16U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FATE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633138399","title":"Piper Sandler Remains a Buy on Fate Therapeutics (FATE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633138399","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633138399?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:59","pubTimestamp":1778068791,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Fate Therapeutics today and set a price target of $6.00. Tenthoff covers the Healt...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-fate-therapeutics-fate-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-fate-therapeutics-fate-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","FATE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633425948","title":"Fate Therapeutics Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of FT819","url":"https://stock-news.laohu8.com/highlight/detail?id=2633425948","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633425948?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:30","pubTimestamp":1777984200,"startTime":"0","endTime":"0","summary":"FDA Chemistry, Manufacturing, and Controls (CMC) Development and Readiness Pilot (CDRP) program supports the acceleration of manufacturing readiness for therapies with expedited clinical development t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/05/3287697/24675/en/Fate-Therapeutics-Selected-for-U-S-FDA-Chemistry-Manufacturing-and-Controls-Development-and-Readiness-Pilot-Program-to-Support-Manufacturing-Readiness-of-FT819.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","SLE","CMC","IE00BFXG1179.USD","LU2237443978.SGD","IE00BHPRN162.USD","IE00B1BXHZ80.USD","LU2237443622.USD","LU0170899867.USD","LU2237443382.USD","LU2746668974.SGD","LU2237443895.HKD","LU2746668461.USD","BK4588","LABU","BK4006","LU0971096721.USD","BK4585","BK4230","BK4022","LU1363072403.SGD","CAR","IE00BKVL7J92.USD","FATE","BK4077","LU2237443465.HKD","LU0149725797.USD","LU2237443549.SGD","LU0267386448.USD","BK4139","LU0882574139.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632955125","title":"Fate Therapeutics posts Phase 1 FT819 lupus data showing B-cell remodeling without chemo conditioning","url":"https://stock-news.laohu8.com/highlight/detail?id=2632955125","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632955125?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:04","pubTimestamp":1777899856,"startTime":"0","endTime":"0","summary":"Fate Therapeutics outlined three ASGCT 2026 presentations highlighting off-the-shelf CAR T-cell candidates spanning autoimmune disease and oncology, with data scheduled for release May 11-15 in Boston.Clinical and translational results from Phase 1 FT819 in systemic lupus erythematosus will be presented in the future, focusing on B-cell remodeling without conditioning chemotherapy while patients remain on background maintenance therapy.FT839 will be discussed in a future oral session as a dual-target program intended to address difficult-to-treat autoimmune diseases by eliminating multiple pathogenic immune-cell populations while sparing non-activated cells.Preclinical FT836 data will be presented in the future, positioning the MICA/B-targeted program for broad anti-tumor activity without conditioning chemotherapy, with potential use alongside standard-of-care regimens.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL72Bz7B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FATE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632546955","title":"Fate Therapeutics Announces Three Presentations at the 2026 Asgct Annual Meeting Highlighting off-the-Shelf Car T-Cell Therapy Pipeline for Cancer and Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2632546955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632546955?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:00","pubTimestamp":1777899602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUAVHLYQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FATE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632554409","title":"Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2632554409","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632554409?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:00","pubTimestamp":1777899600,"startTime":"0","endTime":"0","summary":"SAN DIEGO, May  04, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent s","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/04/3286762/24675/en/Fate-Therapeutics-Announces-Three-Presentations-at-the-2026-ASGCT-Annual-Meeting-Highlighting-Off-the-Shelf-CAR-T-cell-Therapy-Pipeline-for-Cancer-and-Autoimmune-Diseases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLE","BK4230","BK4139","BK4077","BK4022","CAR","FATE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632930352","title":"Fate Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2632930352","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632930352?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:21","pubTimestamp":1777893660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FATE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 04, 2026 07:21 ET (11:21 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FATE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632932837","title":"Fate Therapeutics price target raised to $7 from $5 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2632932837","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632932837?lang=en_us&edition=fundamental","pubTime":"2026-05-04 18:17","pubTimestamp":1777889826,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Fate Therapeutics (FATE) to $7 from $5 and keeps a Buy rating on the shares. The firm says FT819 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fate-therapeutics-price-target-raised-to-7-from-5-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fate-therapeutics-price-target-raised-to-7-from-5-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FATE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632642050","title":"Fate Therapeutics grants 30,200 RSUs to newly hired employee under inducement plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2632642050","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632642050?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:07","pubTimestamp":1777666028,"startTime":"0","endTime":"0","summary":"Fate Therapeutics granted RSUs covering 30,200 common shares to one newly hired non-executive employee on May 1, 2026.Award vests over four years, with 25% vesting on each anniversary of grant date.Grant was made under Fate Therapeutics’ Amended and Restated Inducement Equity Plan.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL3npPBB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2210149790.SGD","FATE","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","BK4112","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014039.USD","BK4585","IE00B64PRP62.GBP","IE00BN0W2W23.USD","LU0314104364.USD","BK4588","SG9999014013.SGD","IE00BN0W2V16.EUR","LU2095319765.USD","SG9999014005.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632864202","title":"Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632864202","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632864202?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:05","pubTimestamp":1777665900,"startTime":"0","endTime":"0","summary":"SAN DIEGO, May  01, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent s","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/01/3286209/24675/en/Fate-Therapeutics-Reports-New-Employee-Inducement-Award-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FATE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631630119","title":"Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2631630119","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631630119?lang=en_us&edition=fundamental","pubTime":"2026-04-30 21:00","pubTimestamp":1777554000,"startTime":"0","endTime":"0","summary":"SAN DIEGO, April  30, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/30/3284910/24675/en/Fate-Therapeutics-Announces-Data-Presentation-of-FT819-Off-the-Shelf-CAR-T-Cell-Product-Candidate-for-Systemic-Lupus-Erythematosus-SLE-at-the-CCR-East-2026-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4077","FATE","BK4022","CCR","BK4139","SLE","CAR","BK4230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630822251","title":"Fate Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630822251","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630822251?lang=en_us&edition=fundamental","pubTime":"2026-04-25 04:05","pubTimestamp":1777061102,"startTime":"0","endTime":"0","summary":"Fate Therapeutics will hold its annual stockholder meeting in San Diego on June 12, 2026.Stockholders will vote on election of three Class I directors.Agenda includes advisory vote on named executive officer compensation.Meeting will also consider ratification of Ernst & Young as independent auditor for fiscal 2026.Another proposal seeks to increase shares reserved under 2022 Stock Option and Incentive Plan by 7,000,000 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fate Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL70bLRq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FATE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627156972","title":"Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at the AACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2627156972","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627156972?lang=en_us&edition=fundamental","pubTime":"2026-04-16 21:00","pubTimestamp":1776344400,"startTime":"0","endTime":"0","summary":"SAN DIEGO, April  16, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/16/3275450/24675/en/Fate-Therapeutics-Announces-Data-Presentation-of-FT839-Next-Generation-Off-The-Shelf-CAR-T-Cell-Product-Candidate-for-the-Broad-Treatment-of-Hematological-Malignancies-and-Autoimmu.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FATE","BK4230","BK4022","CAR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":83,"code":"91000000","status":"200"}]}}